comparemela.com
Home
Live Updates
Xeltis FIH Study of aXess Vascular Graft for Hemodialysis Is Presented : comparemela.com
Xeltis' FIH Study of aXess Vascular Graft for Hemodialysis Is Presented
May 5, 2023—Xeltis recently announced the presentation of 6-month data from its first-in-human (FIH) trial of the company’s aXess vascular
Related Keywords
Italy ,
Porto ,
Portugal ,
Matteo Tozzi ,
University Of Insubria ,
Vascular Access Society In Porto ,
European Union ,
Professor Matteo Tozzi ,
Principal Investigator ,
Vascular Access Society ,
Vascular Surgery ,
Hemodialysis ,
Exeltis ,
Xess Vascular Graft ,
First In Human ,
Dialysis ,
comparemela.com © 2020. All Rights Reserved.